SLNO Smart Money
Soleno Therapeutics, Inc.
1W: +0.1%
1M: +0.4%
3M: +37.7%
YTD: +12.4%
1Y: -29.4%
3Y: +152.4%
5Y: -32.7%
$53.01
Last traded 2026-05-18 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026226
Institutions Holding
-63 vs prior
0.0%
Ownership
-74.20%
0
New
0
Increased
224
Reduced
224
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Huang Michael F. | officer: sr. vp of clinical development | D-Sale to Issuer | 39,823 | $— | $0 | Filing |
| 2026-05-18 | Bir Dawn Carter | director | D-Sale to Issuer | 16,991 | $— | $0 | Filing |
| 2026-05-18 | Fulk Jennifer | officer: chief financial officer | D-Sale to Issuer | 39,200 | $— | $0 | Filing |
| 2026-05-18 | Hirano Patricia C | officer: see remarks | D-Sale to Issuer | 22,702 | $— | $0 | Filing |
| 2026-05-18 | Sinclair Andrew | director | D-Sale to Issuer | 10,491 | $— | $0 | Filing |
| 2026-05-18 | Volck Birgitte | director | D-Sale to Issuer | 17,536 | $— | $0 | Filing |
| 2026-05-18 | Hahn Mark W | director | D-Sale to Issuer | 10,046 | $— | $0 | Filing |
| 2026-05-18 | Joshi Manher | officer: chief development officer | D-Sale to Issuer | 20,171 | $— | $0 | Filing |
| 2026-05-18 | Manning Meredith | officer: chief commercial officer | D-Sale to Issuer | 64,507 | $— | $0 | Filing |
| 2026-05-18 | Norrett Kevin | officer: chief business officer | D-Sale to Issuer | 17,786 | $— | $0 | Filing |
| 2026-05-18 | Pauls Matthew | director | D-Sale to Issuer | 10,491 | $— | $0 | Filing |
| 2026-05-18 | Anish Bhatnagar | officer: chief executive officer | D-Sale to Issuer | 583,656 | $— | $0 | Filing |
| 2026-05-18 | Yen Kristen | officer: see remarks | D-Sale to Issuer | 37,639 | $— | $0 | Filing |
| 2026-03-27 | Huang Michael F. | officer: sr. vp of clinical development | S-Sale | 488 | $31.72 | $15K | Filing |
| 2026-03-27 | Huang Michael F. | officer: sr. vp of clinical development | S-Sale | 1,838 | $31.04 | $57K | Filing |
| 2026-03-27 | Huang Michael F. | officer: sr. vp of clinical development | S-Sale | 4,256 | $30.04 | $128K | Filing |
| 2026-03-27 | Manning Meredith | officer: chief commercial officer | S-Sale | 558 | $31.72 | $18K | Filing |
| 2026-03-27 | Manning Meredith | officer: chief commercial officer | S-Sale | 4,864 | $30.04 | $146K | Filing |
| 2026-03-27 | Manning Meredith | officer: chief commercial officer | S-Sale | 2,100 | $31.04 | $65K | Filing |
| 2026-03-02 | Fulk Jennifer | officer: chief financial officer | A-Grant/Award | 39,200 | $— | $0 | Filing |
| 2026-01-21 | Huang Michael F. | officer: sr. vp of clinical development | A-Grant/Award | 10,400 | $— | $0 | Filing |
| 2026-01-21 | Hirano Patricia C | officer: see remarks | A-Grant/Award | 10,400 | $— | $0 | Filing |
| 2026-01-21 | Yen Kristen | officer: see remarks | A-Grant/Award | 10,400 | $— | $0 | Filing |
| 2026-01-21 | Manning Meredith | officer: chief commercial officer | A-Grant/Award | 28,600 | $— | $0 | Filing |
| 2026-01-21 | Joshi Manher | officer: chief development officer | A-Grant/Award | 4,100 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||